How Mercedes F1 and academics fast-tracked life saving breathing aid

UCL's Professor Clare Elwell gives the inside story of how Mercedes F1 and a team of academics fast-tracked a life saving breathing aid for Covid-19 patients

With the coronavirus pandemic spreading to nearly every country in the world, the number of hospital patients needing respiratory support is becoming unprecedented. It’s not easy for manufacturers to quickly make huge numbers of extra ventilators so there is likely to be an imbalance in supply and demand for the necessary equipment to provide this support.

To alleviate this problem, a team of engineers from UCL (the university in London where I work) and Formula One engine maker Mercedes-AMG HPP have been working flat out to manufacture large numbers of a continuous positive airway pressure (CPAP) device. This machine, similar to those commonly used to treat sleep apnea, can support patients with severe breathing problems, freeing up ventilators for the most critically ill.

As with all things coronavirus related, speed is of the essence. The team has pulled off the task of moving from reverse-engineering an original product and producing a new design, through testing and regulatory approval to full-scale production in under 10 days.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of premium content. Register for free to unlock unlimited access to all of our premium content, as well as the latest technology news, industry opinion and special reports. 

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox